{ event: "article_read", name: `Impact of symptoms and risk of ASMD on patients and caregivers`, author: ``, tags: `Rare Diseases`, publication_date: ``, interaction_type: "content" }
Impact of symptoms and risk of ASMD on patients and caregivers
Objective and Methodology
A survey was conducted to quantify:
Object case: BWS was used to explore 15 ASMD symptoms/risks.
Results
Baseline characteristics
Median age
5 years for patients in the US
3 years for children of parents from the US and the UK
Symptoms
Abdominal enlargement
Abdominal pain
Fatigue
Shortness of breath
Cognitive pretesting interviews
Parents and patients reported difficulty in identifying ASMD-associated symptoms.
Parents were unaware of their child experiencing ASMD symptoms unless indicated by the child.
BWS results
Patients and parents
Fatigue
Joint pain
Abdominal pain
Conclusion
Patients and parents had similar preferences for ranking symptoms/risks.
A wide range of symptoms displayed heterogeneity in samples.
*Severe fatigue: Fatigue so severe that the respondent might need help taking care of themselves and doing daily activities.
ASMD: Acid sphingomyelinase deficiency; BWS: Best–worst scaling; NNPDF: National Niemann-Pick Disease Foundation; NPUK: Niemann-Pick United Kingdom; UK: United Kingdom; US: United States.
By clicking on this link, you will be leaving the Campus Sanofi website and going to another, entirely independent website. Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but its own.